Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When to measure lipid profile after stroke?

Bernard Yan1, Mark Parsons, Sharyn McKay

  • 1Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.

Cerebrovascular Diseases (Basel, Switzerland)
|February 26, 2005
PubMed
Summary

Cholesterol levels fluctuate significantly after an acute ischemic stroke, making early measurements unreliable. For accurate lipid status assessment and effective statin therapy initiation, measurements should be taken 12 weeks post-stroke.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of endovascular thrombectomy for acute ischemic stroke with concurrent intracranial hemorrhage: multicenter registry study.

Journal of neurointerventional surgery·2026
Same author

Accuracy of Distal Internal Carotid Artery Contrast Ratio to Infer Proximal Carotid Disease in the Mobile Stroke Unit.

Stroke (Hoboken, N.J.)·2026
Same author

The Thrombectomy Dilemma in Stroke Patients With Active Cancer: To Treat or Not to Treat?

Journal of stroke·2026
Same author

Impact of long COVID on diverse Australian populations: a multi-site, longitudinal prospective cohort study protocol.

BMJ open·2026
Same author

Identifying novel prodromal symptoms of eclampsia: A two-country, case-control study.

PLoS medicine·2026
Same author

Stroke Etiologies With Intravenous Thrombolysis before Thrombectomy and Functional Outcomes in Anterior Circulation Large Vessel Occlusion.

Annals of neurology·2026

Area of Science:

  • Neurology
  • Cardiology
  • Clinical Chemistry

Background:

  • Acute decreases in total cholesterol (TC) are known in myocardial infarction but inconsistent in prior stroke studies.
  • Lipid level timing is crucial for ischemic stroke management due to recent statin trial findings.
  • This study investigates optimal lipid measurement timing post-stroke, hypothesizing an acute TC decrease and 12-week return to baseline.

Purpose of the Study:

  • To determine the optimal timing for lipid measurements following an acute ischemic stroke.
  • To evaluate the dynamic changes in lipid profiles in the 12 weeks after stroke onset.

Main Methods:

  • A prospective, observational study involving 50 acute ischemic stroke patients.
  • Fasting lipid profiles (TC, LDL, HDL, triglycerides) measured <48 hours, 4 weeks, and 12 weeks post-ictus.

Related Experiment Videos

  • Patients included statin-naïve individuals, those on statins, and those newly commenced on statins.

    • Main Results:

    • In statin-naïve patients, a significant increase in total cholesterol was observed at the 12-week follow-up.
    • Cholesterol levels demonstrated variability in the acute phase and early weeks post-stroke.
    • 38 out of 50 patients completed the 12-week follow-up.

    Conclusions:

    • Cholesterol levels measured during the acute phase of stroke are unreliable indicators of a patient's true lipid status.
    • Initiating statin therapy should be guided by lipid measurements taken approximately 12 weeks after the stroke event.
    • This timing allows for a more stable and representative assessment of lipid levels for treatment decisions.